TCRT 10-Q: SEC filing

Alaunos Therapeutics

Filed with the SEC on · accession 0001193125-26-463638

TCRT filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -1.8% by the first close after the filing.

Summary of the filing

Alaunos Therapeutics filed its Q3 2026 10-Q, reporting continued net losses and minimal revenue, while disclosing a September 2026 registered direct offering and an October 2026 private placement of preferred stock to Velaris Therapeutics.

Key details

FilerAlaunos Therapeutics, Inc.
Private placement investorVelaris Therapeutics, Inc.
Collaboration partnerSolasia Pharma K.K.
Licensing/royalty counterpartyThe University of Texas MD Anderson Cancer Center

How TCRT stock reacted

Close before

$1.63

Nov 13, 2026

First close after

-1.84%

$1.60

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for TCRT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TCRT?

Click here

Frequently asked questions

What did TCRT file with the SEC on Nov 16, 2026?

TCRT filed a 10-Q (SEC filing). Alaunos Therapeutics filed its Q3 2026 10-Q, reporting continued net losses and minimal revenue, while disclosing a September 2026 registered direct offering and an October 2026 private placement of preferred stock to Velaris Therapeutics.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did TCRT stock react to this filing?

TCRT closed at $1.63 before the filing and $1.60 on Nov 16, 2026 (-1.84%).

Other TCRT SEC filings

Get alerts when TCRT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days